Ghost Tree Capital’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-561,510
Closed -$10.4M 86
2017
Q3
$10.4M Buy
561,510
+186,510
+50% +$3.23M 2.2% 12
2017
Q2
$6.21M Hold
375,000
1.29% 32
2017
Q1
$5.17M Buy
375,000
+175,000
+88% +$2.81M 0.96% 43
2016
Q4
$3.79M Hold
200,000
0.91% 43
2016
Q3
$4.44M Buy
200,000
+80,000
+67% +$1.5M 0.72% 48
2016
Q2
$2.19M Buy
120,000
+10,000
+9% +$172K 0.63% 44
2016
Q1
$2M Sell
110,000
-40,000
-27% -$647K 1.13% 32
2015
Q4
$2.53M Buy
+150,000
New +$2.55M 1.04% 34
2015
Q2
Sell
-150,000
Closed -$3.29M 93
2015
Q1
$3.29M Buy
+150,000
New +$3.24M 1.18% 43

Other funds holding ENTL

Ghost Tree Capital's ENTL Position: Q4 2017 in Review

Ghost Tree Capital sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 561,510 shares — an estimated $10.4M sold.

Ghost Tree Capital first reported a position in ENTL in Q1 2015 and held it in 9 quarters. The position peaked at $10.4M in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Ghost Tree Capital reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Ghost Tree Capital sold 561,510 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $10.4M.
  • Ghost Tree Capital first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
  • Ghost Tree Capital's Entellus Medical, Inc. Common Stock position peaked at $10.4M in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Ghost Tree Capital's 13F filing for Q4 2017, filed 14 Feb 2018.